• Pioglitazone: Selective PPARγ Agonist for Metabolic Disorder

  2026-05-15

  Pioglitazone is a potent, selective PPARγ agonist widely used in metabolic disorder research, including type 2 diabetes mellitus and inflammatory models. Its ability to modulate macrophage polarization and STAT signaling is verifiable in both cellular and animal systems. This article presents atomic, evidence-backed insights into pioglitazone’s mechanism, benchmarks, and workflow integration.

• AO/PI Double Staining Kit: Reliable Cell Viability & Death D

  2026-05-15

  The AO/PI Double Staining Kit offers a rapid, direct method to distinguish viable, apoptotic, and necrotic cells in heterogeneous populations, addressing the challenge of accurate cell viability and death discrimination in research workflows. It is best suited for fluorescence-based assays in cell biology where clear discrimination among these cell states is required; it is not intended for non-fluorescent or in vivo imaging applications.

• Cyclophilin A Loss Confers Cyclosporine Resistance in Mice

  2026-05-14

  This study demonstrates that cyclophilin A is essential for cyclosporine-mediated immunosuppression, with Ppia−/− mice showing resistance to the drug. These findings clarify the molecular mechanism of selective calcineurin inhibition and have direct implications for designing and interpreting immune response suppression protocols in transplantation immunology research.

• JZL184: Applied Protocols for Monoacylglycerol Lipase Inhibi

  2026-05-14

  JZL184 unlocks precise endocannabinoid system modulation, making it a go-to monoacylglycerol lipase inhibitor for pain and neuropharmacology research. Explore detailed workflows, troubleshooting insights, and translational use-cases that set JZL184 apart for both in vitro and in vivo studies.

• Homoharringtonine Rapidly Clears SARS-CoV-2 in Preclinical M

  2026-05-13

  The referenced study demonstrates that homoharringtonine, a cytotoxic alkaloid known for its anti-leukemic properties, achieves rapid clearance of SARS-CoV-2 from the upper respiratory tract in both animal models and human patients. This work establishes mechanistic and translational evidence for homoharringtonine as a potential first-line antiviral intervention in future coronavirus epidemics.

• BAF53a Drives Glioma Progression via EMT: Prognostic Evidenc

  2026-05-13

  This study identifies BAF53a as a prognostic biomarker in glioma, demonstrating its role in promoting tumor cell proliferation, invasion, and epithelial-mesenchymal transition (EMT). The findings provide mechanistic insight into glioma aggressiveness and highlight BAF53a as a candidate therapeutic target.

• In Vitro Metrics for Drug Response: Insights from Cancer Stu

  2026-05-12

  Schwartz's dissertation rigorously dissects how standard in vitro metrics—relative viability and fractional viability—differ in capturing cancer drug effects, revealing that most agents impact both cell proliferation and death in distinct proportions and timing. These findings prompt more precise assay design and drug evaluation strategies for translational oncology.

• Ethacridine Lactate Monohydrate: Optimizing Antiseptic Workf

  2026-05-12

  Ethacridine lactate monohydrate delivers high-fidelity microbial control for sensitive biochemical and stem cell assays, leveraging its robust solubility and purity. Integrating insights from super-enhancer regulation studies, this guide details advanced protocols, troubleshooting, and experimental advantages for researchers demanding reproducibility and contamination-free workflows.

• MTT Assays for Mitochondrial Therapeutics: Translational Ins

  2026-05-11

  This article explores the critical role of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) in enabling translational researchers to validate mitochondrial-targeted therapies, with a special focus on the evolving landscape of in vitro cell proliferation and metabolic activity assays. By bridging mechanistic understanding with strategic workflow guidance, we contextualize MTT’s impact on the study of myocardial ischemia-reperfusion injury and engineered mitochondrial transplantation, offering practical recommendations and a forward-looking vision for translational research teams.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Protocol and QC Guid

  2026-05-11

  The Cy3 Goat Anti-Mouse IgG (H+L) Antibody addresses the challenge of sensitive and specific detection of mouse IgG primary antibodies in immunofluorescence, flow cytometry, and western blotting. It is best suited for research workflows requiring robust signal amplification and fluorescent detection but is not intended for diagnostic or clinical applications.

• Angiotensin 1/2 (2-7) Peptide: Applied Workflows & Innovatio

  2026-05-10

  Angiotensin 1/2 (2-7) empowers advanced modeling of the renin-angiotensin system for both cardiovascular and viral pathogenesis research. This rigorously purified peptide unlocks new experimental strategies, offering reproducibility and mechanistic clarity that streamline complex assay development.

• Lipo3K Transfection Reagent: Advancing Difficult Cell Transf

  2026-05-09

  Lipo3K Transfection Reagent streamlines high-efficiency delivery of DNA, siRNA, and mRNA, enabling robust gene expression and RNA interference studies in even the most refractory cells. With ultra-low toxicity and a novel enhancer system, it stands as a superior alternative to legacy lipid transfection reagents for advanced molecular research.

• KPT330 Enhances Cas9 Precision by Regulating mRNA Nuclear Ex

  2026-05-08

  This article reviews the recent discovery that KPT330, a selective inhibitor of nuclear export, indirectly improves the specificity of CRISPR-Cas9 genome and base editing by modulating Cas9 mRNA export. The findings suggest a novel, non-protein-based approach for enhancing gene editing precision in mammalian cells, with important methodological and translational implications.

• Cy5 TSA Fluorescence System Kit: Spatial Proteome Mapping Re

  2026-05-08

  Explore how the Cy5 TSA Fluorescence System Kit elevates spatial proteome mapping with horseradish peroxidase catalyzed tyramide deposition, providing unmatched sensitivity and specificity for advanced immunohistochemistry and in situ hybridization workflows.

• QRICH1 Drives HMGB1 Secretion in HBV-Linked Hepatic Fibrosis

  2026-05-07

  This study identifies QRICH1 as a key effector of endoplasmic reticulum (ER) stress, enhancing the translocation and secretion of HMGB1 in hepatocytes during HBV-induced hepatic fibrosis. The findings reveal molecular mechanisms connecting viral infection, ER stress, and pro-fibrotic signaling, with implications for targeting QRICH1-mediated pathways in liver disease.

11116 records 1/742 page Next 12345 下5页 Last page